Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Activist investor Starboard Value has taken a stake in Becton Dickinson and is pushing the $72bn medical technology company to sell its life sciences division, according to people familiar with the matter.
The hedge fund has met the group’s management team and sent a letter to the board imploring the company to sell or spin off the unit, which makes products used in…
Read the full article here
